The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stocks buoyed by China factory PMI, US-China trade news

Mon, 01st Apr 2019 08:35

(Sharecast News) - Stocks are kicking-off the new quarter on the front foot, helped by stronger-than-expected economic data out of the People's Republic of China and further positive news on the state of US-China trade talks.But ahead of another round of indicative votes in the British Parliament, later on Monday, on possible alternatives to the Prime Minister's proposed withdrawal agreement, a warning from Easyjet reminded investors of the toll that uncertainty surrounding the UK's exit from the European Union was taking on companies, as did another weak reading on German factory activity.In a statement, Easyet said: "Macroeconomic uncertainty and many unanswered questions surrounding Brexit are together driving weaker customer demand."As of 0835 GMT the FTSE 100 was ahead by 0.82% to 7,338.90. In parallel, front month Brent crude oil futures were adding 1.3% to $68.48 a barrel on the ICE and the pound was rising 0.08% to 1.1629.Also out of China, ahead of vice premier Liu He's trip to Washington this week for another round of trade negotiations, Beijing said it would extend a freeze on retaliatory tariffs on US car exports and add the opioid fentanyl to a list of controlled substances.Against that backdrop, all eyes were on a round of global manufacturing data due out at the start of the week, as investors tried to gauge whether a bottom was about to fall into place for the sector, which in turn might signal greater strength in stockmarkets around the world - or not.On that note, readings on Chinese factory sector activity in March released overnight printed ahead of forecasts, although economists appeared somewhat unconvinced by the figures, telling clients that at least some further weakness might yet be on the cards.Survey compiler Caixin's Chinese manufacturing Purchasing Managers' Index for March printed at 50.8, versus a reading of just 49.5 for the month before and economists' forecasts for a reading of 50.0.Some market commentary was also highlighting the possibility that seasonal factors, tied to the timing of the Lunar New Year in 2019, might lie behind that strength.Commenting on the Caixin PMI, Julian Evans-Pritchard at Capital Economics said: "there is now a decent chance that growth in China may bottom out slightly earlier than we had previously anticipated. That said, we still think growth could weaken again in the near-term. The recent trajectory of credit growth still points to a slowdown in the coming months."Going the other way, IHS Markit's factory sector PMIs for Germany and France were both revised lower.For later in the session, investors will be focusing on two key economic reports out of the States, those on retail sales covering the month of February at 1330 GMT, followed by the ISM's manufacturing sector index for March at 1500 GMT.Also due out was a manufacturing sector PMI for the month of March in the UK at 0930 GMT.In broker note action, analysts at Berenberg revised their recommendation for shares of Royal Mail from 'sell' to 'hold'.Fasten your seatbelts: Easyjet eyes potential turbulence aheadEasyJet said uncertainty over Brexit and the economy made the budget airline more cautious on its outlook as the airline reported first-half trading in line with guidance. The FTSE 100 carrier expects to post a headline pre-tax loss of £275m for the six months to the end of March as revenue rises 7.3% to about £2.34bn. Airlines traditionally report losses for the winter months. Revenue per seat will be about 7.4% lower, which easyJet said was in line with guidance issued in January. Costs per seat rose about 1.4% as crew costs increased.Ferrexpo announced a further delay to its annual results to give more time for an independent review of the company's donations to the charity Blooming Land. The FTSE 250 miner said it would publish its 2018 results on or before 25 April. It had previously delayed publication from 20 March to 3 April. An independent committee is examining the company's donations to Blooming Land, a Ukrainian charity set up to coordinate Ferrexpo's corporate and social responsibility programme.Rio Tinto said iron ore shipments from Pilbara in Australia would be at the low end of guidance after a cyclone damaged a port used to transport the commodity. Production from Pilbara will be about 14m tonnes lower than expected in 2019, the FTSE 100 miner said. As a result shipments of iron ore from the region will be at the low end of its guidance of 338m to 350m tonnes.AstraZeneca announced on Monday that the US Food and Drug Administration (FDA) has granted 'Breakthrough Therapy Designation' (BTD) for the MEK 1/2 inhibitor and potential new medicine selumetinib, which it is developing alongside its partner Merck. The FTSE 100 pharmaceuticals giant said the designation was for the treatment of paediatric patients aged three years and older with neurofibromatosis type 1 symptomatic or progressive, inoperable plexiform neurofibromas, which it described as a rare, incurable genetic condition.Sports Direct has prepared a template letter for other shareholders in Debenhams to use as part of boss Mike Ashley's push to install himself as chief executive of the troubled department store group. Sports Direct said on Monday that it had been contacted by "a number" of other concerned shareholders in Debenhams, concerned they will see the value of their shares wiped out by Debenhams financial restructuring plans and "expressing their support" for Ashley's appointment as CEO there.Market MoversFTSE 100 (UKX) 7,339.01 0.82%FTSE 250 (MCX) 19,234.48 0.61%techMARK (TASX) 3,540.75 0.95%FTSE 100 - RisersAshtead Group (AHT) 1,916.50p 3.45%WPP (WPP) 837.20p 3.26%Melrose Industries (MRO) 188.15p 2.73%Glencore (GLEN) 325.75p 2.45%BHP Group (BHP) 1,892.00p 2.35%Johnson Matthey (JMAT) 3,210.00p 2.16%Rio Tinto (RIO) 4,554.50p 2.10%Evraz (EVR) 633.20p 2.06%Smith (DS) (SMDS) 342.80p 2.05%AstraZeneca (AZN) 6,261.00p 2.05%FTSE 100 - FallerseasyJet (EZJ) 1,036.50p -7.25%International Consolidated Airlines Group SA (CDI) (IAG) 504.04p -1.55%TUI AG Reg Shs (DI) (TUI) 727.20p -1.14%SSE (SSE) 1,177.00p -0.84%Severn Trent (SVT) 1,961.50p -0.73%Fresnillo (FRES) 865.80p -0.57%Kingfisher (KGF) 233.70p -0.47%Centrica (CNA) 113.78p -0.37%Associated British Foods (ABF) 2,431.00p -0.33%Admiral Group (ADM) 2,165.00p -0.23%FTSE 250 - RisersContour Global (GLO) 179.80p 4.17%Ferrexpo (FXPO) 257.35p 3.94%Babcock International Group (BAB) 509.80p 3.30%Amigo Holdings (AMGO) 186.00p 3.20%John Laing Group (JLG) 391.80p 3.11%Royal Mail (RMG) 245.68p 3.10%Premier Oil (PMO) 96.67p 2.90%Weir Group (WEIR) 1,601.00p 2.76%Ted Baker (TED) 1,600.00p 2.70%Investec (INVP) 454.10p 2.67%FTSE 250 - FallersStobart Group Ltd. (STOB) 146.19p -3.82%Wizz Air Holdings (WIZZ) 2,936.98p -2.43%TBC Bank Group (TBCG) 1,522.00p -1.42%Telecom Plus (TEP) 1,500.00p -1.32%Just Group (JUST) 60.50p -1.14%Kier Group (KIE) 359.40p -1.05%HICL Infrastructure (HICL) 154.50p -0.90%Inmarsat (ISAT) 550.20p -0.86%Civitas Social Housing (CSH) 95.24p -0.79%Savills (SVS) 897.50p -0.77%
More News
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.